question · intermediate · partly written
Do people make antibodies to PEG on carriers, and do they clear the carrier faster?
Anti-PEG antibody effects on lipid nanoparticle clearance and reactions were seen only in a search summary in report 5 and are not held.
Observation
What is known
What is not
Prevalence of anti-PEG antibodies, whether they accelerate clearance or cause complement reactions in people, and whether the reactions seen on the label are due to PEG: a rat study and a small preprint were seen only via a search summary and are not relied on. 1
Our inference
What would settle it
Primary human studies pairing anti-PEG titres with carrier clearance and reaction rates. 1
Our inference
Still open here
- Primary sources on anti-PEG antibodies in patients.
Not yet written: Hypotheses, What is missing, Who works on it.
Linked from
Sources
- Onpattro (patisiran) lipid complex injection US prescribing information. Alnylam Pharmaceuticals (2025). regulatory, not peer reviewed; opened 2026-11-17 all records citing this
- Akinc A, Querbes W, De S, Qin J, et al.. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther (2010). paper; opened 2026-11-17 all records citing this
- Voke E, Arral ML, Squire HJ, Lin TJ, et al.. Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo. Nat Commun (2025). paper; opened 2026-11-17 all records citing this
- Amit's dictation of 2026-11-17: what the atlas must contain. Kept in the atlas repository; not published.
Where it sits on the map
History of this record (2)
This record has been changed 2 times, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.
- Kind
- big-open
- Register
- open-question
- Status
- partly written
- Last updated
- 2026-11-19
- Record
- content/questions/anti-peg-antibody-responses.json